Liver transplantation for alcoholic cirrhosis with anti-HCV antibodies

Transpl Int. 1997;10(4):289-92. doi: 10.1007/s001470050059.

Abstract

The results of orthotopic liver transplantation (OLT) in patients with alcoholic liver cirrhosis (ALC) are currently similar to those obtained in patients with other indications. However, the frequent association of ALC with hepatitis C virus (HCV) infection may impair these results. We retrospectively studied the consequences of HCV infection on survival and graft function in 59 patients with ALC undergoing OLT. Patients were classified into two groups depending on their HCV serology before transplantation: group 1 comprised 24 anti-HCV-positive patients, and group 2, 35 anti-HCV-negative patients. Patient and graft survival were similar in both groups. Liver function tests 1 and 4 years after OLT showed AST and ALT values that were significantly higher in group 1 patients and post-transplant histologically proven chronic hepatitis was found in 45% and 61% of these patients at 1 and 4 years, respectively. We conclude that pretransplant HCV infection in patients with ALC does not affect survival after OLT. However, one must bear in mind the high incidence of post-transplant chronic hepatitis secondary to recurrence of HCV infection and be cautious when drawing this conclusion.

MeSH terms

  • Adult
  • Female
  • Hepatitis C Antibodies / blood*
  • Humans
  • Liver Cirrhosis, Alcoholic / surgery*
  • Liver Transplantation*
  • Male
  • Middle Aged

Substances

  • Hepatitis C Antibodies